Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer
Clinical trial NCT03786081 · TERMINATED
Trial details
- NCT number
- NCT03786081
- Sponsor
- Seagen, a wholly owned subsidiary of Pfizer
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-27
- Primary completion
- 2026-03-19
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.